Catalyst Wire Dossier Catalyst Wire Dossier

immune plasma (high-titer)

· National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for immune plasma (high-titer), covering 2019-06-14 to 2019-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Comparing the Efficacy and Safety of High-Titer Versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A [Phase 3]

See pricing